Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hormone therapy, estrogen metabolism, and risk of breast cancer in the Women's Health Initiative Hormone Therapy Trial.
Mackey RH, Fanelli TJ, Modugno F, Cauley JA, McTigue KM, Brooks MM, Chlebowski RT, Manson JE, Klug TL, Kip KE, Curb JD, Kuller LH. Mackey RH, et al. Among authors: brooks mm. Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2022-32. doi: 10.1158/1055-9965.EPI-12-0759. Epub 2012 Aug 29. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22933427 Free PMC article. Clinical Trial.
Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Althouse AD, Abbott JD, Sutton-Tyrrell K, Forker AD, Lombardero MS, Buitrón LV, Pena-Sing I, Tardif JC, Brooks MM; BARI 2D Study Group. Althouse AD, et al. Among authors: brooks mm. Diabetes Care. 2013 Oct;36(10):3269-75. doi: 10.2337/dc12-2265. Epub 2013 Jun 4. Diabetes Care. 2013. PMID: 23735723 Free PMC article. Clinical Trial.
Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.
Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, Mulukutla S, Aboyans V, Brooks MM; BARI 2D Study Group. Althouse AD, et al. Among authors: brooks mm. Diabetes Care. 2014;37(5):1346-52. doi: 10.2337/dc13-2303. Epub 2014 Mar 4. Diabetes Care. 2014. PMID: 24595631 Free PMC article. Clinical Trial.
Lipoprotein subclasses and endogenous sex hormones in women at midlife.
El Khoudary SR, Brooks MM, Thurston RC, Matthews KA. El Khoudary SR, et al. Among authors: brooks mm. J Lipid Res. 2014 Jul;55(7):1498-504. doi: 10.1194/jlr.P049064. Epub 2014 May 22. J Lipid Res. 2014. PMID: 24852168 Free PMC article. Clinical Trial.
Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.
El Khoudary SR, Santoro N, Chen HY, Tepper PG, Brooks MM, Thurston RC, Janssen I, Harlow SD, Barinas-Mitchell E, Selzer F, Derby CA, Jackson EA, McConnell D, Matthews KA. El Khoudary SR, et al. Among authors: brooks mm. Eur J Prev Cardiol. 2016 May;23(7):694-703. doi: 10.1177/2047487315607044. Epub 2015 Sep 18. Eur J Prev Cardiol. 2016. PMID: 26385249 Free PMC article.
Characterizing the trajectories of vasomotor symptoms across the menopausal transition.
Tepper PG, Brooks MM, Randolph JF Jr, Crawford SL, El Khoudary SR, Gold EB, Lasley BL, Jones B, Joffe H, Hess R, Avis NE, Harlow S, McConnell DS, Bromberger JT, Zheng H, Ruppert K, Thurston RC. Tepper PG, et al. Among authors: brooks mm. Menopause. 2016 Oct;23(10):1067-74. doi: 10.1097/GME.0000000000000676. Menopause. 2016. PMID: 27404029 Free PMC article.
334 results